HealthTech Welcomes VP of Revenue Cycle Services

December 23, 2025 5:17 AM

HealthTech is pleased to announce that Margaret Bistrovich has joined HealthTech as the new vice president of Revenue Cycle Services. Bistrovich has over 25 years of health care experience in operations, client relationship management, revenue cycle management, and EDI technology solutions. Previously, as CBO Director, Revenue Cycle Management at Catholic Health Initiatives, Bistrovich enhanced financial performance across multi-state hospital...

Read more

Cellbxhealth PLC Announces Holding(s) in Company

December 23, 2025 5:00 AM

Cellbxhealth PLC: TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB0034330679Issuer NameCelLBxHealth plcUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameConifer Management, L.L.C.City of registered office (if applicable)New YorkCountry of registered office (if applicable)United States4. Details of the...

Read more

IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease

December 23, 2025 2:00 AM

IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A)(STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, has received regulatory and ethical approvals for a Phase Ib study of IRL757 to assess safety, tolerability, and signal finding in patients with Parkinson's disease who experience apathy. The study will be conducted at 16 sites across four European countries and is fully funded by...

Read more

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

December 23, 2025 1:20 AM

MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases, today outlined the evolution of its global reimbursement strategy to enable scalable patient access and sustainable commercial growth for next-generation neurotherapeutics.Building on a decade of clinical development and five years of focused...

Read more

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

December 22, 2025 11:20 PM

Gruber Plastic Surgery announced today that Dr. Meegan Gruber, MD, PhD, a board-certified plastic surgeon and founder of Gruber Plastic Surgery in Tampa, Florida, has been named a 2026 Exceptional Woman in Medicine by Castle Connolly, with the recognition slated to be featured in New York Magazine. The Castle Connolly Exceptional Women in Medicine distinction highlights women physicians recognized for outstanding accomplishments, leadership, and...

Read more

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

December 22, 2025 10:55 PM

In a world of packed calendars, remote meetings, school pickups, and nonstop obligations, planning cosmetic surgery isn't just about choosing a procedure it's about planning recovery. Meegan Gruber, MD, PhD, board-certified plastic surgeon and founder of Gruber Plastic Surgery in Tampa, Florida, has released a 2026 Recovery-Logistics Guide designed to help patients make practical, safety-first plans for time off, home support, transportation,...

Read more

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

December 22, 2025 10:40 PM

With elective cosmetic surgery continuing to grow and patients increasingly comparing surgeons online, Meegan Gruber, MD, PhD, a board-certified plastic surgeon at Gruber Plastic Surgery in Tampa, Florida, released a 2026 Patient Safety Checklist designed to help patients make confident, informed decisions before scheduling surgery. "Cosmetic surgery is personal, and it should never feel rushed," said Dr. Gruber. "In 2026, the best decision a...

Read more

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

December 22, 2025 10:20 PM

Gruber Plastic Surgery in Tampa, Florida is sharing updated 2025 patient education and consultation planning insights on one of the most-requested facial rejuvenation strategies: pairing a facelift with eyelid surgery (blepharoplasty) for a balanced, natural-looking refresh. The practice notes that patients researching "facelift Tampa," "eyelid surgery Tampa," and "blepharoplasty Tampa" are increasingly asking the same question: "Should I treat...

Read more

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

December 22, 2025 7:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today applauds President Trump's recent Executive Order (the "Order") to improve cannabidiol research to better inform patients and doctors. The Order directs agencies within the Department of Health and Human Services to allow...

Read more

Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector

December 22, 2025 4:55 PM

MMJ International Holdings, MMJ BioPharma Cultivation and MMJ BioPharma Labs ("MMJ"), a pioneer in pharmaceutical-grade cannabinoid drug development, today issued a statement following President Donald Trump's historic executive order directing the reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act. The order marks a decisive shift in federal policy-formally recognizing cannabis' credible therapeutic...

Read more

LiveForeverHealth Launches Full-Stack Hormone & Telemedicine Franchise Model

December 22, 2025 3:30 PM

Live Forever Health™ officially announces the launch of its national franchising program, offering a unique opportunity for entrepreneurs and physicians to deploy the company's telemedicine-integrated physical clinic model. This "full-stack" approach blends the convenience of national online care-now available in all 50 states-with the essential clinical rigor of local, in-person monitoring and services. By standardizing high-quality care with...

Read more

The Naderi Center Announces the Rise of "Facial Harmony" as 2025's Leading Trend in Aesthetic Surgery and Dermatology

December 22, 2025 1:00 PM

The Naderi Center for Plastic Surgery and Dermatology, a nationally recognized destination for advanced facial aesthetics, announces a significant shift in patient priorities for 2025: a move away from isolated cosmetic procedures toward a comprehensive, harmony-based approach that blends surgical refinement, nonsurgical enhancements, and high-level skin rejuvenation. According to board-certified facial plastic surgeon Dr. Shervin Naderi,...

Read more

Sannabis S.A.S., a Colombia Licensed Cannabis Operator, Addresses U.S. Marijuana Rescheduling and Potential Implications for International Medical Cannabis Travel and Trade

December 22, 2025 12:10 PM

Sannabis S.A.S., a federally licensed and regulated medical cannabis operator in Colombia, today issued commentary on the ongoing U.S. federal process to reschedule marijuana under the Controlled Substances Act ("CSA") and the potential legal, policy, and international trade implications such a change could have for medical cannabis patients and compliant pharmaceutical suppliers.The discussion follows recent actions by U.S. President Donald J....

Read more

Diversatek Healthcare Rebrands With Modern Website

December 22, 2025 11:00 AM

Diversatek Healthcare, a provider of gastrointestinal devices and diagnostic testing systems, recently unveiled a comprehensive rebrand featuring a redesigned website, bold new colors, and an updated mission statement. Introduced in November 2025, the rebrand will be implemented across all digital, print, and social media channels. This initiative reinforces Diversatek Healthcare's brand presence among healthcare providers, while also...

Read more

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

December 22, 2025 9:00 AM

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and...

Read more

Balancing a Kidney Diet: Optimizing Nutrition Through Personalization

December 22, 2025 8:45 AM

DaVita:For individuals managing chronic kidney disease (CKD), dietary choices significantly impact health outcomes and disease progression. A kidney-friendly diet often involves managing intake of nutrients like sodium, phosphorus and potassium.Holiday gatherings at the end of the year can often focus on sharing meals and festive foods with loved ones. This is a critical time to support people in finding balance between celebrating and following...

Read more

Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling

December 22, 2025 8:00 AM

Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company") welcomes the recent U.S. rescheduling of cannabis and the potential introduction of a Medicare program that could allow patient access to much-needed, potentially life-changing CBD therapies, including topical formulations. Ovation's science-based topical / transdermal cannabis products are supported by clinical evidence and demonstrated commercial success through its...

Read more

1933 Industries Issues Final Reminder to 2024 Debenture Holders: December 22 Is the Deadline to Convert

December 22, 2025 7:37 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) issues a final reminder to holders of its unsecured convertible debentures issued in 2024 (the "2024 Debentures") that today, December 22, 2025, is the final day to submit conversion instructions in accordance with the terms of the debenture agreement.The maturity date of the debentures is December 31, 2025; however, pursuant to the debenture terms, conversion...

Read more

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

December 22, 2025 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that it has entered into non-binding letter of intent (LOI) with Reliant AI Inc. ("Reliant"), a decision-intelligence company for the life sciences, specializing in generative AI, to collaborate on the...

Read more

1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter

December 22, 2025 7:00 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2026") for the three months ended October 31, 2025 and 2024. All amounts expressed are in Canadian dollars.The Company owns 100%[1] of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary centred on the medical...

Read more